Update on Novartis Influenza Vaccine Acquisition
Filed with ASX · · 2 pages · English
Later from CSL
- Announcement of buy-back - Appendix 3C
- Half Year Accounts
- IDELVION(R) (rFIX-FP) - CHMP recommendation
- IDELVION(R) (rFIX-FP) - FDA approval
- Changes relating to buy-back - Appendix 3D
Follow CSL into a list and get an email when it puts out news.
Follow CSL